Abstract:Abstract Background Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE Kyoto has not been validated in an animal model. This study intended to establish an ApoE Kyoto murine model and to further compare the pathologic differences between ApoE Kyoto and ApoE Sendai. Method Male ApoE-deficient mice, 3 months of age, were divided into five groups, including the AD-ApoE Sendai, AD-ApoE Kyoto, AD-ApoE3, AD-eGFP, and ApoE (−/−) groups. The first four groups received recombinant adenovirus that contained the entire coding regions of the human ApoE Sendai and ApoE Kyoto , apoE3 , and eGFP genes, respectively. Fasting blood and urine samples were collected at multiple time points. Lipid profiles and urine albumin–creatinine ratio were measured. Renal and aortic histopathologic alterations were analyzed. Results After virus injection, plasma human ApoE was detected and rapidly reached the maximum level at 4–6 days in the AD-ApoE Kyoto and AD-ApoE Sendai groups (17.4 ± 3.1 μg/mL vs.: 22.2 ± 4.5 μg/mL, respectively) and at 2 days in the AD-ApoE3 group (38.4 μg/mL). The serum total cholesterol decreased by 63%, 65%, and 73% in the AD-ApoE Kyoto, AD-ApoE Sendai and AD-ApoE3 groups, respectively. There were no significant changes in serum triglyceride and urinary albumin–creatinine ratio among the five groups. Typical lipoprotein thrombi with positive ApoE staining were detected in the AD-ApoE Kyoto and AD-ApoE Sendai groups. The Oil-red O-positive glomerular area tended to be higher in the AD-ApoE Kyoto group (9.2%) than in the AD-ApoE Sendai (3.9%), AD-ApoE3 (4.8%), AD-eGFP (2.9%), and ApoE (−/−) (3.6%) groups. The atherosclerotic plaque area in the aorta was lower in the group injected with various ApoE mutations than in the group without injection of ApoE mutation. Conclusions In this animal study, we first established an ApoE Kyoto mutation murine model and confirmed its pathogenic role in LPG. Our results suggested that LPG may be more severe with the ApoE Kyoto than with the ApoE Sendai.

Kidney Gene Expression Changes of Human ApoE_4-Transgenic Mice by Cdna Array Analysis

Genes Encoding Pir51, Beclin 1, RbAp48 and Aldolase B Are Up or Down-Regulated in Human Primary Hepatocellular Carcinoma.

The Expression and Significance of Apolipoprotein E in Kidney of Rats with Glomerulosclerosis.

Changes of Blood Biochemical Markers in Apolipoprotein E Deficient Mice

Gene Expression Profiles of Primary Retinal Pigment Epithelial Cells from Apolipoprotein E Knockout and Human Apolipoprotein E2 Transgenic Mice.

Signaling pathway factors expression in renal tissue of apoE-knockout mice.

Prokaryotic Expression of Human Apolipoprotein E and Analyses of the Molecular Interaction Between ApoE and PrP Proteins in Vitro

Signaling Pathway Factors Expression in Renal Tissue of Apoe-Knockout Mice

APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease

Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice

Alteration of Vascular Urotensin Ii Receptor in Mice with Apolipoprotein E Gene Knockout

Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoter

Identification of Gene Expression Changes in the Aorta of Apoe Null Mice Fed a High-Fat Diet

ApoE and ABCG2 expression

Systematic analysis of long non-coding RNA and mRNA expression changes in ApoE-deficient mice during atherosclerosis.

[Study on Differentially Expressed Gene of the Liver of Treble Fatty Metabolism Genes Mutant Mice Using Cdna Microarray].

Apoe Expression in Glomerulus and Correlation with Glomerulosclerosis Induced by Adriamycin in Rats.

Differential Proteomic Analysis of Liver in Apoe/ldlr Double-Gene Mutant Mice

Relationship Between Apolipoprotein E Gene Polymorphism and Total Cholesterol Level in Patients with Kidney Diseases

Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice

Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2